A randomised trial of mode of delivery in women infected with the human immunodeficiency virus

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 3, 1998, Pages 281-285

  Newell, Marie Louise ^a   Parazzini, Fabio ^c   Mandelbrot, Laurent ^e   Peckham, Catherine ^a   Semprini, Augusto ^d   Bazin, Brigitte ^f   Darbyshire, Janet ^b   Sanchez, Emilia ^g   Pardi, Giorgio ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d University Hospital San Paolo   (Italy)

^e Hospital Cochin ^*  (France)

^f INSERM   (France)

^g Subdirecció General de Planificació Sanitaria   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINAL DELIVERY;

CESAREAN SECTION; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; EUROPE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PATIENT SATISFACTION; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0031889853     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10087.x     Document Type: Article

References (25)

1. Scarlatti G. Paediatric HIV infection. Lancet 1996; 348: 863–867.
2. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-I) transmission by use of a Markov model. Am J Epidemiol 1995; 142: 1330–1337.
3. Consensus Workshop Siena. Strategies for prevention of perinatal transmission of HIV infection. J Acquir Immune Defic Syndr Hum Retrowirol 1995; 8: 161–178.
4. Landesman SH, Kalish LA, Bums DN et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother-to-child. N Engl J Med 1996; 334: 1617–1623.
5. Mandelbrot L, Mayaux M, Bongain A, Berrebi A, Moudoub Jeanpetit Y, Benifla J et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996; 175: 661–667.
6. European Collaborative Study. Vertical transmission of HIV-I: maternal immune status andobstetric factors. AIDS 1996; 10: 1675–1681.
7. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343: 1464–1467.
8. Dunn DT, Newell ML, Mayaux MJ et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J AIDS 1994; 7: 1064–1066.
9. Scaravelli G, Thome C, Newell M. The management of pregnancy and delivery in HIV infected women in Europe. Eur J Obstet Gynecol Reprod Biol 1995; 62: 7–13.
10. Mayaux MJ, Teglas JP, Mandelbrot L et al. Acceptability and impact of zidovudine prevention on mother-to-child HIV-1 transmission in France. J Pediatr 1997. In press.
11. Nielsen TF, Hokegard K. Postoperative cesarean section morbidity: a prospective study. Am J Obstet Gynecol 1983; 146: 911–916.
12. Semprini AE, Castagna C, Ravizza M et al. The incidence of complications after caesarean section in 156 HIV positive women. AIDS 1995; 9: 913–917.
13. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173–1180.
14. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSheny GD et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from motherto infant. N Engl J Med 1996; 335: 1621–1629.
15. Centers For Disease Control. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994; 43 RR-11: 1–20.
16. Centers For Disease Control. US Public Health Service recommendations for human immunodeficiency virus counselling and voluntary testing for pregnant women. MMWR Morb Morfal wkry Rep 1995; 44: 1–15.
17. Kind C, Brandle B, Wyler C et al. Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur J Pediatr 1992; 151: 442–448.
18. Rudin C, Cadi C, Schnriger H et al. HIV und Schwangerschafi. Schweiz Med Wochenschr 1995; 125: 2322–2329.
19. Newell M, Peckham CS. Working towards a European strategy for intervention to reduce vertical transmission of HIV. Br J Obstet Gynaecol 1994; 101: 192–196.
20. Evans L. Italy has Europe's highest caesarean section rate. BMJ 1995; 310: 487.
21. Zelen M. A new design for randomised clinical trials. N Engl J Med 1979; 300: 1242–1245.
22. Penn ZJ, Steer PJ, Grant A. A multicentre randomised controlled trial comparing elective and selective caesarean section for the delivery of the preterm breech infant. Br J Obstet Gynaecol 1996; 103: 684–689.
23. Thomton JG, Lilford RJ. Preterm breech babies and randomised trials of rare conditions. Br J Obstet Gynaecol 1996; 103: 611–613.
24. Anonymous. Your baby is in a trial. Lancet 1995; 345: 805–806.
25. Mould TAJ, Chong S, Spencer JAD, Gallivan S. Women's involvement with the decision preceding their caesarean section and their degree of satisfaction. Br J obstet Gynaecol 1996; 103: 1074–1077.